US based Alkermes Inc is to buy Elan's drug formulation and manufacturing unit in a deal worth an estimated $960 million. The cash and stock transaction will see Elan Drug Technologies and Alkermes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results